The Audioconference agenda is set forth in Eastern Daylight Time below:
|
|
1:00 pm |
Welcome and Introduction of Faculty
Matthew Hay, Publisher, Rx Compliance Report (Moderator)
|
1:05 pm |
The New Congressional Landscape
John F. Kamp, J.D., Ph.D.
|
1:20 pm |
Big Pharma and the New Democratic Congress
Adonis Hoffman, Esq.
- Strengths, weaknesses, opportunities and threats for the industry
- Balancing business and consumer interests
- Threats facing Direct-to-Consumer advertising
|
|
1:35 pm |
Big Pharma and the New Democratic Congress
Daniel A. Kracov, Esq.
- The prospects for PDUFA and potential for FDA drug safety legislative "reform"
- Likely areas of Congressional oversight and investigations
- Prospects for clinical trial registry and database legislation
|
|
1:50 pm |
Pharma and the New Democratic Congress
Steven E. Irizarry, Esq.
- The potential impact on off-label promotion
- Possible scenarios for continuing medical education
|
|
2:05 pm |
Moderators Comments and Panel Discussion
|
2:15 pm |
Questions and Comments
|
2:30 pm |
Audioconference Adjournment
|
